Tag: therapeutic plasma exchange market insights

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theTherapeutic Plasma Exchange Market?

The therapeutic plasma exchange market is expected to grow due to the high prevalence of hematological disorders. Hematological disorders are conditions affecting blood and blood-forming tissues, and their prevalence is rising due to genetic factors and lifestyle changes. Therapeutic plasma exchange is used to remove harmful substances from the plasma in conditions such as autoimmune hemolytic anemia. In August 2023, the Leukemia and Lymphoma Society projected a 2.3% increase in myeloma diagnoses from 2021 to 2023. Therefore, the prevalence of hematological disorders is driving the therapeutic plasma exchange market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp

#How Will the CAGR of the Therapeutic Plasma Exchange Market Influence Its Overall Growth by 2034?

The therapeutic plasma exchange market size has grown strongly in recent years. It will rise from $1.47 billion in 2024 to $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. Growth is driven by the rise of immunological diseases, technological advancements, increased awareness, expanded indications, and improved understanding of pathophysiology.

The therapeutic plasma exchange market is expected to grow to $2.32 billion in 2029, with a CAGR of 9.5%. Growth drivers include the rising geriatric population, clinical guidelines, regulatory environment, hospital infrastructure, healthcare investments, and reimbursement policies. Key trends include personalized therapies, automation integration, collaborative initiatives, and telemedicine adoption.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15683

Which Cutting-Edge Market Trends Are Expected to Drive theTherapeutic Plasma Exchange Market’s Growth?

Major companies in the therapeutic plasma exchange market are forming strategic partnerships to integrate technologies and expand market reach. For example, in July 2022, Terumo Blood and Cell Technologies, a US-based tech company, partnered with Eliaz Therapeutics Inc. to address acute kidney injury (AKI) and sepsis-induced AKI (S-AKI). This collaboration focuses on selectively removing the inflammatory protein Gal-3 from blood plasma, using Terumo’s Spectra Optia Apheresis System and ETI’s XGal-3 column, with studies beginning in large animals.

What Are the Leading Market Players Impacting theTherapeutic Plasma Exchange Market’s Growth Trend?

Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc., Japan Medical Supply Co. Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

How Are the Key Segments of the Therapeutic Plasma Exchange Market Driving Opportunities and Innovations?

The therapeutic plasma exchange market covered in this report is segmented –

1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)

2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications

3) By Technology: Centrifugation, Membrane Separation

4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion Centers, Other End Users

Subsegments:

1) By Therapeutic Plasma Exchange (Tpe): Manual Tpe, Automated Tpe

2) By Double Filtered Plasmapheresis (Dfpp): Single-Stage Dfpp, Multi-Stage Dfpp

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15683&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theTherapeutic Plasma Exchange Market?# Market Expansion?

North America was the largest region in the therapeutic plasma exchange market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Therapeutic Plasma Exchange Market 2025, By The Business Research Company:

Biosimilar Therapeutic Peptides Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptide-global-market-report

Non-Therapeutic Biomolecules Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Respiratory Devices And Equipment (Therapeutic) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 15% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the therapeutic plasma exchange market grown in recent years?

In the past few years, the market size of therapeutic plasma exchange has increased significantly. It is anticipated to rise from $1.47 billion in 2024 to $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. The growth during this historical period is due to the rising incidence of immune disorders, advancements in technology, heightened awareness and education, proliferation of indications, and a greater comprehension of pathophysiology.

How is the therapeutic plasma exchange market size expected to evolve during the forecast period?

The therapeutic plasma exchange market size is expected to see strong growth in the next few years. It will grow to $2.32 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the rising geriatric population, clinical evidence and guidelines, regulatory environment, hospital infrastructure and healthcare investments, healthcare expenditure, and reimbursement policies. Major trends in the forecast period include personalized therapies, integration of automation, collaborative initiatives, and telemedicine integration.

Get your therapeutic plasma exchange market report here!

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Which key drivers are propelling the therapeutic plasma exchange market’s growth?

The therapeutic plasma exchange market is predicted to see significant growth due to the increased prevalence of hematological disorders. These blood disorders are conditions that impact the blood and related tissues such as bone marrow, lymph nodes, and the spleen. Factors like genetic predispositions, environmental factors, and changes in lifestyle are contributing to the rise in hematological disorders. Therapeutic plasma exchange (TPE) is often used as a treatment method for these disorders, serving to eliminate harmful substances from the plasma, such as autoantibodies in autoimmune hemolytic anemia and immune complexes in thrombotic thrombocytopenic purpura, consequently alleviating the severity of the disease, thus improving patient prognosis. For example, in August 2023, the Leukemia and Lymphoma Society, a professional organization based in the US, predicts that the number of myeloma diagnoses will increase by approximately 2.3% from 2021 to 2023, rising from 34,920 cases to 35,730. As such, this surge in hematological disorders is fueling the expansion of the therapeutic plasma exchange market.

What are the market segments in the therapeutic plasma exchange industry?

The therapeutic plasma exchange market covered in this report is segmented –

1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)

2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications

3) By Technology: Centrifugation, Membrane Separation

4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion Centers, Other End Users

Subsegments:

1) By Therapeutic Plasma Exchange (Tpe): Manual Tpe, Automated Tpe

2) By Double Filtered Plasmapheresis (Dfpp): Single-Stage Dfpp, Multi-Stage Dfpp

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp

Who are the key players steering the development of the therapeutic plasma exchange market?

Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc., Japan Medical Supply Co. Ltd.

What key trends are currently impacting the therapeutic plasma exchange market’s development?

Major businesses in the therapeutic plasma exchange market are embracing strategies of forming partnerships to boost technology assimilation and amplify their market influence. These strategic partnerships are typically a cooperative alliance between two or more firms, pooling their resources, know-how, and efforts with the aim of accomplishing shared targets. For example, in July 2022, Terumo Blood and Cell Technologies, a technology firm based in the US, joined forces with Eliaz Therapeutics Inc., a US-based medical device firm that specializes in therapeutic apheresis for kidney-related and inflammatory ailments. This partnership is geared towards tackling acute kidney injury (AKI) and sepsis-induced AKI (S-AKI) by specifically eliminating the Gal-3 inflammatory protein from blood plasma. Given the high fatality ratio linked with AKI, the partnership seeks to investigate new remedies using Terumo’s Spectra Optia Apheresis System and ETI’s XGal-3 column. The initial studies will concentrate on large animals, advancing eventually to human clinical trials. Terumo, renowned for its inventive approaches in therapeutic apheresis, has previously cooperated on projects aimed at conditions like triple-negative breast cancer and COVID-19.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15683

Which regions are most influential in expanding the therapeutic plasma exchange market?

North America was the largest region in the therapeutic plasma exchange market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Biosimilar Therapeutic Peptides Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptide-global-market-report

Non-Therapeutic Biomolecules Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Respiratory Devices And Equipment (Therapeutic) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the Therapeutic Plasma Exchange Market, and What Are the Key Drivers?

The market for therapeutic plasma exchange has witnessed significant expansion in the past few years. The market, which currently stands at $1.47 billion in 2024, is projected to increase to $1.62 billion by 2025, reflecting a compound annual growth rate (CAGR) of 9.8%. This robust growth during the previous years is linked to the rise of immunological diseases, advancements in technology, heightened awareness and education, broader indications, as well as a better comprehension of pathophysiology.

The market size for therapeutic plasma exchange is projected to witness substantial expansion in the upcoming years, estimated to reach $2.32 billion by the year 2029, with a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period can be credited to various factors such as an increasing elderly population, clinical research and guidelines, regulatory frameworks, advancements in hospital infrastructure and healthcare investments, healthcare spending, and reimbursement policies. Key trends observed during this forecast period encompass individualized treatments, implementation of automation, partnership initiatives, and the integration of telemedicine.

How Are the key drivers Contributing to the Expansion of the Therapeutic Plasma Exchange Market?

The rise in hematological disorders is anticipated to boost the therapeutic plasma exchange market’s growth. Hematological disorders, also referred to as blood disorders, are ailments affecting the blood and tissues that form blood such as lymph nodes, spleen, and bone marrow. The increase in these disorders is attributed to factors like genetic predispositions, environmental impacts, and lifestyle modifications. Therapeutic plasma exchange (TPE) is beneficial in the treatment of hematological disorders as it aids in getting rid of pathogenic substances from the plasma. This includes autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, helping to reduce disease severity and enhance patient outcomes. For instance, the Leukemia and Lymphoma Society, a professional organization based in the US, projected an approximate rise of 2.3% in myeloma diagnoses from 2021 to 2023 – increasing from 34,920 to 35,730 in August 2023. Thus, the increasing prevalence of hematological disorders is fuelling the expansion of the therapeutic plasma exchange market.

Request Your Free Therapeutic Plasma Exchange Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp

Which Companies Are Leading the Charge in Expanding the Therapeutic Plasma Exchange Market?

Major companies operating in the therapeutic plasma exchange market are:

• Medica S.p.A.

• Fresenius SE and Co. KGaA

• Medtronic Plc.

• Asahi Kasei Corporation

• Toray Industries Inc.

What New Trends Are Reshaping the Therapeutic Plasma Exchange Market and Its Opportunities?

Many key players in the therapeutic plasma exchange market are pursuing strategic partnerships as a way to augment technology integration and broaden their market presence. A strategic partnership generally implies a mutual alliance between multiple organizations wherein they amalgamate their resources, expertise, and endeavors to accomplish shared goals or objectives. For instance, in July 2022, Terumo Blood and Cell Technologies, an American technology firm, joined forces with Eliaz Therapeutics Inc., – a U.S. medical device firm adept in therapeutic apheresis for inflammatory and kidney-related diseases. They aim to address acute kidney injury (AKI) and Sepsis-induced AKI (S-AKI) through the selective removal of the inflammatory protein Gal-3 from blood plasma. Given the high mortality rates linked to AKI, the partnership intends to investigate new treatments using Terumo’s Spectra Optia Apheresis System and ETI’s XGal-3 column. Preliminary studies will be conducted on large animals before advancing to human clinical trials. Terumo, recognized for its innovation in therapeutic apheresis, has previously entered collaborative projects targeting diseases like triple-negative breast cancer and COVID-19.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

What Are the Primary Segments of the Therapeutic Plasma Exchange Market and Their Roles in Growth Dynamics?

The therapeutic plasma exchange market covered in this report is segmented –

1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)

2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications

3) By Technology: Centrifugation, Membrane Separation

4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion Centers, Other End Users

Subsegments:

1) By Therapeutic Plasma Exchange (Tpe): Manual Tpe, Automated Tpe

2) By Double Filtered Plasmapheresis (Dfpp): Single-Stage Dfpp, Multi-Stage Dfpp

What Are the Top Regions Fueling Growth in the Therapeutic Plasma Exchange Market?

North America was the largest region in the therapeutic plasma exchange market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Defines the Scope of the Therapeutic Plasma Exchange Market?

Therapeutic plasma exchange (TPE) refers to a medical procedure used to treat certain autoimmune diseases and other conditions. During TPE, blood is removed from the body, plasma (the liquid portion of the blood) is separated from the blood cells, and then the blood cells are returned to the body, often after being mixed with a replacement fluid. This process helps remove harmful substances from the blood, such as autoantibodies or toxins, which can contribute to various diseases.

Browse Through More Similar Reports By The Business Research Company:

Biosimilar Therapeutic Peptides Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptide-global-market-report

Non-Therapeutic Biomolecules Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Respiratory Devices And Equipment (Therapeutic) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: